Антигипертензивная эффективность ирбесартана

1. Клиническая фармакология. Под ред. В.Г.Кукеса. Изд. 4, М.: ГЭОТАР-Медиа, 2008; с. 392-5.

2. Диагностика и лечение артериальной гипертензии. Российские рекомендации, 4-я редакция. Системные гипертензии 2010; 3: 5-26.

3. Fogari R, Ambrosoli S, Corradi L et al. Irbesartan Multicenter Investigator's Group. 24-Hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring. J Hypertens 1997; 15 (12-1): 1511-8.

4. Kassler-Taub K, Littlejohn T, Elliot W и др. Irbesartan. Losartan Study Investigators. Comparative Efcacy of Two Angiotensin II Receptor Antagonist, Irbesartan and Losartan, in Mild-to-Moderate Hypertension. Am J Hypertens 1998; 11 (4-1): 445-53.

5. Oparil S, Guthrie R, Lewin AJ и др. Irbesartan. Losasartan Study Investigators. Clin Ther 1998; 20 (3): 398-409.

6. Mancia G, Korlipara K, van Possum P et al. An ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan. Blood Press Monit 2002; 7 (2): 135-342.

7. Mimran A, Ruilope L, Kerwin L et al. A rindomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension. J Hum Hypertens 1998; 12 (3): 203-8.

8. Larochelle P, Flack JM, Marbury TC и др. Irbesartan Multicenter Investigators. Effects and tolerability of irbesartan vs enalapril in patients with severe hypertension. Am J Cardiol 1997; 80 (12): 1613-5.

9. Stumpe KO, Haworth D, Hoglund C et al. Comparison of the Angiotensin II Receptor Antagonist Irbesartan with Atenolol for Treatment of Hypertension. Blood Press 1998; 7 (1): 31-7.

10. Чазова И.Е., Ратова Л.Г. Комбинированная терапия артериальной гипертонии. М., Медиа Медика. 2007; 183 с.